Читать «Кето-навигатор» онлайн - страница 163

2. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med. 2005; 37 (5): 347–356.

3. Jung SH, Ha KH, Kim DJ. Visceral Fat Mass Has Stronger Associations with Diabetes and Prediabetes than Other Anthropometric Obesity Indicators among Korean Adults. Yonsei Med J. 2016 May 1; 57 (3): 674–680.

4. Sheth SG, Chopra Sanjive. Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults [Интернет]. UpToDate. 2018. Доступно по адресу http://www.uptodate.com/contents/epidemiology-clinical-features-anddiagnosis-of-nonalcoholic-fatty-liver-disease-in-adults.

5. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011 Aug; 34 (3): 274–285.

6. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011 Jan; 140 (1): 124–131.

7. Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015 Sep 8; 314 (1): 1021–1029.

8. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol. 2016 Jan 5; 419: 44–59.

9. Там же.

10. Claria J, Nguyen BT, Madenci AL, et al. Diversity of lipid mediators in human adipose tissue depots. Am J Physiol Cell Physiol. 2013 Jun 15; 304 (12): C1141–1149.

11. Claria J, Dalli J, Yacoubian S, et al. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol. 2012 Sep 1; 189 (5): 2597–2605.

12. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol. 2016 Jan 5; 419: 44–59.

13. White PJ, Arita M, Taguchi R, et al. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes. 2010 Dec; 59 (12): 3066–30673.

14. Neuhofer A, Zeyda M, Mascher D, et al. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes. 2013 Jun; 62 (6): 1945–1956.

15. Hellmann J, Tang Y, Kosuri M, et al. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 2011 Jul; 25 (7): 2399–2407.

16. Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol. 2016 Jan 5; 419: 44–59.

17. Там же.

18. Guyenet SJ, Carlson SE. Increase in adipose tissue linoleic acid of US adults in the last half century. Advances in Nutrition. 2015 Nov 1; 6 (6): 660–664.